Page last updated: 2024-09-04

cd 437 and paclitaxel

cd 437 has been researched along with paclitaxel in 2 studies

Compound Research Comparison

Studies (cd 437)	Trials (cd 437)	Recent Studies (post-2010) (cd 437)	Studies (paclitaxel)	Trials (paclitaxel)	Recent Studies (post-2010) (paclitaxel)
134	0	26	31,874	5,729	15,395

Protein Interaction Comparison

Protein	Taxonomy	paclitaxel (IC50)
Integrin beta-3	Homo sapiens (human)	0.034
Integrin alpha-V	Homo sapiens (human)	0.034
ATP-dependent translocase ABCB1	Homo sapiens (human)	2.598
Botulinum neurotoxin type A	Clostridium botulinum	5.2
UDP-glucuronosyltransferase 2B7	Homo sapiens (human)	4.9
UDP-glucuronosyltransferase 1-6	Homo sapiens (human)	4.9
Substance-K receptor	Homo sapiens (human)	6.125
UDP-glucuronosyltransferase 1A1	Homo sapiens (human)	4.9
UDP-glucuronosyltransferase 1A4	Homo sapiens (human)	4.9
UDP-glucuronosyltransferase 2B10	Homo sapiens (human)	4.9
Delta-type opioid receptor	Homo sapiens (human)	4.202
Tyrosine-protein kinase Mer	Homo sapiens (human)	4.9
Tubulin beta-3 chain	Homo sapiens (human)	0.0082
Beta-tubulin	Leishmania donovani	1
Nucleotide-binding oligomerization domain-containing protein 2	Homo sapiens (human)	7.9433
Solute carrier organic anion transporter family member 1B3	Homo sapiens (human)	0.26
Solute carrier organic anion transporter family member 1B1	Homo sapiens (human)	0.28

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, A; Parekh, HK; Soprano, DR	1
Garattini, E; Gianni', M; Terao, M	1

Other Studies

2 other study(ies) available for cd 437 and paclitaxel

Article	Year
Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer research, 2001, Oct-15, Volume: 61, Issue:20 Topics: Antineoplastic Agents; Blotting, Northern; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Paclitaxel; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Tumor Cells, Cultured	2001
Correspondence re: A. Kumar et al., cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res., 61: 7552-7555, 2001. Cancer research, 2002, Apr-01, Volume: 62, Issue:7 Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Paclitaxel; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids	2002

Article

Year

Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.

Cancer research, 2001, Oct-15, Volume: 61, Issue:20

Topics: Antineoplastic Agents; Blotting, Northern; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Oligonucleotide Array Sequence Analysis; Ovarian Neoplasms; Paclitaxel; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids; Tumor Cells, Cultured

2001

Correspondence re: A. Kumar et al., cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res., 61: 7552-7555, 2001.

Cancer research, 2002, Apr-01, Volume: 62, Issue:7

Topics: Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Humans; Ovarian Neoplasms; Paclitaxel; Receptors, Retinoic Acid; Retinoic Acid Receptor gamma; Retinoids

2002

chemdatabank.com